Fig. 5
From: Real world effectiveness of chemotherapy plus bevacizumab with immunotherapy in colorectal cancer
Association between baseline expression of tumor environment surface proteins and partial response or stable disease for ≥ 16 weeks (Immunohistochemistry results).
